Dr. Samih Hussein Raad, MD

Dr. Raad practices at Beebe Medical Group in Lewes, Delaware.

Dr. Raad's NPI, 1497160600, was assigned on June 25, 2014. Dr. Raad graduated from University of Oklahoma College of Medicine in 2020. Dr. Raad holds Delaware license C1-0013609.

Dr. Raad's primary practice is Beebe Medical Group, at 1515 Savannah Rd, Lewes, DE 19958 in Sussex County. The practice phone is (302) 313-2300.

Dr. Raad's primary practice is Beebe Medical Group in Lewes, Delaware. Dr. Raad is also affiliated with Beebe Healthcare. The medical group on file is Beebe Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raad practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Raad's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Raad's licenses on file in 2 states: Delaware and Oklahoma.

CMS data shows 1,900 Medicare services from Dr. Raad across 18 procedure codes in 2024, for 735 Medicare patients. Medicare paid $164,234 for them.

CMS counts 735 Medicare patients who saw Dr. Raad in 2024. The largest group is 65 to 74, with 331 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raad's median patient age at 73, with 45% women.

In 2024, Dr. Raad wrote 1,864 Medicare Part D claims for 348 patients. 39% of them were for generic drugs. CMS names the drug for 1,731 of them, across 27 drugs with 11 or more claims each, at $1,409,767 in total drug cost. In 2023, CMS named 1,589 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Raad for performance year 2024, reported as part of a group. Dr. Raad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Raad as offering telehealth.

Dmand AI links 9 papers to Dr. Raad, published from 2016 to 2020. 2017 was the busiest year, with 2. The most frequent topics are Ultrasonography. Dr. Raad has published most often in J Ophthalmol. Dr. Raad's most frequent co-authors are Khalil J. Diab, MD, Karen Suzanne Allen, MD and Anita Barikian.

CMS Open Payments shows 336 general payments to Dr. Raad from 46 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 89% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,642.

Dr. Raad graduated from University of Oklahoma College of Medicine in 2020.